DGAP-News: Eckert & Ziegler Awarded for Excellent Training Quality


 

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous
Eckert & Ziegler Awarded for Excellent Training Quality

20.03.2019 / 13:29
The issuer is solely responsible for the content of this announcement.


 

Berlin, 20 March 2019. Eckert & Ziegler has been awarded for "excellent training quality" by the Berlin Chamber of Industry and Commerce (IHK). The award recognizes the quality of training of young employees.

The Chamber of Industry and Commerce (IHK) evaluated the training at Eckert & Ziegler based on more than 40 criteria. Amongst other things, the general conditions, the implementation and the supervision of the training were evaluated. The auditors were able to get a personal impression of the training conditions during an on-site visit. Especially convincing were the onboarding processes, the individual operation plans adapted to the training framework plan, and the team-building measures. In addition, Eckert & Ziegler impressed with the fact that trainees are involved at an early stage in independent projects which promotes social skills.

"We are very pleased about this award. The best proof that the education at Eckert & Ziegler is of a high standard are our great trainees", explained Dr Harald Hasselmann, member of the Executive Board of Eckert & Ziegler AG. "The IHK certification shows that we are on the right track. It will make Eckert & Ziegler an even more attractive company for school leavers. Significant for the very good training at our company is the large number of former trainees who support us as specialists in various departments of our company. The hiring rate is around 70%."

Since 2005, Eckert & Ziegler has been regularly training industrial clerks and IT specialists for system integration. The application deadline for a training position at Eckert & Ziegler is mid-March every year. The apprenticeship begins in September of the same year.

Click here for photo material: https://www.ezag.com/award-ceremony-2019


About Eckert & Ziegler.

The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The Group is an international leader in some of its fields. The company employs around 800 people at 20 locations worldwide, 240 of them are working at the headquarters in Berlin-Buch. Eckert & Ziegler has been listed on the stock exchange since 1999 and is listed in the Prime Standard of the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).

Contributing to saving lives.


Your contact for questions:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com



20.03.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

789761  20.03.2019 

fncls.ssp?fn=show_t_gif&application_id=789761&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 138,63 168,71 178,49 176,14 180,44 222,26 246,09
EBITDA1,2 26,62 32,14 43,13 44,64 57,04 55,52 58,83
EBITDA-Marge3 19,20 19,05 24,16 25,34 31,61 24,98
EBIT1,4 17,97 23,39 32,06 33,69 47,45 44,54 45,45
EBIT-Marge5 12,96 13,86 17,96 19,13 26,30 20,04 18,47
Jahresüberschuss1 15,12 16,89 22,48 23,11 34,66 29,75 26,77
Netto-Marge6 10,91 10,01 12,59 13,12 19,21 13,39 10,88
Cashflow1,7 26,83 21,21 40,43 36,79 33,86 34,30 47,40
Ergebnis je Aktie8 0,70 0,78 1,07 1,11 1,66 1,41 1,26
Dividende8 0,20 0,30 0,42 0,45 0,50 0,50 0,17
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 36,500 Halten 772,78
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
22,81 26,26 0,89 40,15
KBV KCV KUV EV/EBITDA
3,49 16,30 3,14 12,62
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 0,05 0,14 28.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
14.05.2024 09.08.2024 14.11.2024 22.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-7,67% -1,70% -11,62% -21,67%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei EQS abrufen


Medtech , 565970 , EUZ , XETR:EUZ